Breaking Business News | Breaking business news AM | Breaking Business News PM

The New York Post: Novavax stock soars after start of late-stage COVID-19 vaccine trial

26 Sep 2020

Novavax’s stock price surged Friday after the biotech firm started a key late-stage trial of its experimental coronavirus vaccine.

Read the full article here.
This content was originally published by - Top Stories. Original publishers retain all rights. It appears here for a limited time before automated archiving. By - Top Stories

Covid-19 – Johns Hopkins University

Download brochure

Introduction brochure

What we do, case studies and profiles of some of our amazing team.